Clinical Trial Update: A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass [Phase 2]

View source ↗

Summary

A Phase 2 GLP-1 receptor PET imaging substudy within the VER-A-T1D trial evaluates the effects on beta cell mass in diabetes patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Snippet

Sponsor: Radboud University Medical Center | Conditions: Diabetes Mellitus | Phase 2 | Status: UNKNOWN